Stephens Consulting, LLC Astrazeneca PLC Transaction History

Stephens Consulting, LLC

$309 Billion
Q4 2025

A detailed history of Stephens Consulting, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Stephens Consulting, LLC holds 693 shares of AZN stock, worth $61,954. This represents 0.02% of its overall portfolio holdings.

Number of Shares

693

Previous 659 5.16%

Holding current value

$61,954

Previous $50.5 Million 26.01%

% of portfolio

0.02%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 13, 2026	BUY	$81.15 - $89.4 $2,759 - $3,039	34 Added 5.16%	693 $63.7 Million
Q3 2025 Oct 15, 2025	SELL	$68.72 - $82.11 $31,817 - $38,016	-463 Reduced 41.27%	659 $50.5 Million
Q2 2025 Jul 25, 2025	BUY	$64.87 - $75.0 $4,151 - $4,800	64 Added 6.05%	1,122 $78.4 Million
Q1 2025 Apr 17, 2025	BUY	$65.37 - $77.96 $26,278 - $31,339	402 Added 61.28%	1,058 $77.8 Million
Q3 2024 Oct 18, 2024	BUY	$76.67 - $87.62 $76 - $87	1 Added 0.15%	656 $51.1 Million

Q2 2024 Jul 29, 2024	SELL	$66.81 - $80.83 $6,681 - $8,083	-100 Reduced 13.25%	655 $51.1 Million
Q1 2024 Apr 17, 2024	SELL	$61.03 - $69.57 $7,750 - $8,835	-127 Reduced 14.4%	755 $51.1 Million
Q3 2023 Oct 25, 2023	BUY	$64.85 - $71.7 $64 - $71	1 Added 0.11%	882 $59.7 Million
Q1 2023 Apr 19, 2023	BUY	$63.15 - $71.6 $126 - $143	2 Added 0.23%	881 $61.1 Million
Q4 2022 Jan 19, 2023	SELL	$54.21 - $70.44 $11,709 - $15,215	-216 Reduced 19.73%	879 $59.6 Million
Q3 2022 Jan 19, 2023	BUY	$53.02 - $135.75 $6,892 - $17,647	130 Added 13.47%	1,095 $60 Million
Q2 2022 Jan 19, 2023	SELL	$59.26 - $71.14 $5,926 - $7,114	-100 Reduced 9.39%	965 $63.7 Million
Q1 2022 Jan 19, 2023	BUY	$55.72 - $67.12 $2,674 - $3,221	48 Added 4.72%	1,065 $70.6 Million
Q4 2021 Jan 19, 2023	BUY	$54.02 - $63.83 $54,938 - $64,915	1,017 New	1,017 $59.3 Million

Others Institutions Holding AZN

# of Institutions

1,521

Shares Held

502M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stephens Consulting, LLC with notifications on news.

Account

Stephens Consulting, LLC Astrazeneca PLC Transaction History